DECOMPENSATED CIRRHOSIS
Clinical trials for DECOMPENSATED CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new DECOMPENSATED CIRRHOSIS trials appear
Sign up with your email to follow new studies for DECOMPENSATED CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smartphone app keep liver patients out of the hospital?
Disease control Recruiting nowThis study tests whether a digital home monitoring system called CirrhoCare can reduce unplanned hospital visits for people with decompensated cirrhosis. About 214 adults with cirrhosis will be randomly assigned to use the CirrhoCare system at home or receive standard care. The m…
Matched conditions: DECOMPENSATED CIRRHOSIS
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
Engineered immune cells aim to calm liver damage in first human trial
Disease control Recruiting nowThis study tests a new treatment called RTX001 for people with severe liver cirrhosis that has caused complications. RTX001 uses the patient's own immune cells (macrophages) that are modified in a lab to reduce inflammation and scarring in the liver. The trial will enroll 30 adul…
Matched conditions: DECOMPENSATED CIRRHOSIS
Phase: PHASE1, PHASE2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated May 11, 2026 20:40 UTC